Combined immunodeficiency in a patient with c-Rel deficiency

Slides:



Advertisements
Similar presentations
Early exposure to cow's milk protein is protective against IgE-mediated cow's milk protein allergy Yitzhak Katz, MD, Nelly Rajuan, MSc, Michael R. Goldberg,
Advertisements

Impaired TH17 responses in patients with chronic mucocutaneous candidiasis with and without autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy 
Immune deficiency caused by impaired expression of nuclear factor-κB essential modifier (NEMO) because of a mutation in the 5′ untranslated region of.
Cor a 1–reactive T cells and IgE are predominantly cross-reactive to Bet v 1 in patients with birch pollen–associated food allergy to hazelnut  Claudia.
Janet Chou, MD, Yousef R. Badran, MD, Christina S. K
Plasmacytoid dendritic cell depletion in DOCK8 deficiency: Rescue of severe herpetic infections with IFN-α 2b therapy  Sevgi Keles, MD, Haifa H. Jabara,
Autoimmunity due to RAG deficiency and estimated disease incidence in RAG1/2 mutations  Karin Chen, MD, Wilfred Wu, MD, Divij Mathew, BA, Yuhua Zhang,
Alexandra Kazaks, MA, RD, Janet Y. Uriu-Adams, PhD, Judith S
Homozygous N-terminal missense mutation in TRNT1 leads to progressive B-cell immunodeficiency in adulthood  Glynis Frans, MPharm, Leen Moens, PhD, Heidi.
A homozygous mucosa-associated lymphoid tissue 1 (MALT1) mutation in a family with combined immunodeficiency  Haifa H. Jabara, BSc, Toshiro Ohsumi, PhD,
Advances in food allergy in 2015
Impaired TH17 responses in patients with chronic mucocutaneous candidiasis with and without autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy 
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Differential cytokine induction by the human skin–associated autoallergen thioredoxin in sensitized patients with atopic dermatitis and healthy control.
Cor a 1–reactive T cells and IgE are predominantly cross-reactive to Bet v 1 in patients with birch pollen–associated food allergy to hazelnut  Claudia.
Hypomorphic Janus kinase 3 mutations result in a spectrum of immune defects, including partial maternal T-cell engraftment  Federica Cattaneo, MD, Mike.
Alefacept (lymphocyte function-associated molecule 3/IgG fusion protein) treatment for atopic eczema  Dagmar Simon, MD, Jennifer Wittwer, MD, Ganna Kostylina,
Penicillium marneffei infection and impaired IFN-γ immunity in humans with autosomal- dominant gain-of-phosphorylation STAT1 mutations  Pamela P.W. Lee,
Anti–IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL- 5 and IL-5 receptor levels  Miguel L. Stein, MD, Joyce M. Villanueva,
Chronic mucocutaneous candidiasis associated with an SH2 domain gain-of-function mutation that enhances STAT1 phosphorylation  Ali Sobh, MD, Janet Chou,
Long-term immune reconstitution after matched unrelated hematopoietic stem cell transplantation for immunodeficiency  Vy Hong-Diep Kim, MD, Brenda Reid,
Is 9 more than 2 also in allergic airway inflammation?
Recurrent viral infections associated with a homozygous CORO1A mutation that disrupts oligomerization and cytoskeletal association  Christina S. Yee,
Azzedine Tahiat, PharmD, Yousef R
Janet Chou, MD, Yousef R. Badran, MD, Christina S. K
Yuichi Teraki, MD, Aika Sakurai, MD, Seiichi Izaki, MD 
Kathleen R. Bartemes, BA, Gail M. Kephart, BS, Stephanie J
Clinical studies of the DP1 antagonist laropiprant in asthma and allergic rhinitis  George Philip, MD, Janet van Adelsberg, MD, Thomas Loeys, PhD, Nancy.
Hematopoietic stem cell transplantation corrects WIP deficiency
Interleukin receptor-associated kinase-4 deficiency impairs Toll-like receptor–dependent innate antiviral immune responses  Douglas R. McDonald, MD, PhD,
Hematopoietic stem cell transplantation outcomes for 11 patients with dedicator of cytokinesis 8 deficiency  Waleed Al-Herz, MD, Julia I. Chu, MD, Jet.
Peter M. Wolfgram, MD, David B. Allen, MD 
Toll-like receptor 9, transmembrane activator and calcium-modulating cyclophilin ligand interactor, and CD40 synergize in causing B-cell activation  Esra.
Allison K. Martin, BS, Douglas G. Mack, PhD, Michael T
Use of ruxolitinib to successfully treat chronic mucocutaneous candidiasis caused by gain-of-function signal transducer and activator of transcription.
Impaired humoral and cellular immune responses to influenza vaccination in chronic obstructive pulmonary disease patients  Aurélien Parpaleix, PhD, Laurent.
A peptide derived from the Wiskott-Aldrich syndrome (WAS) protein-interacting protein (WIP) restores WAS protein level and actin cytoskeleton reorganization.
β-Agonist enhances type 2 T-cell survival and accumulation
Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: Clinical and immunologic outcomes.
Thymic stromal lymphopoietin–activated invariant natural killer T cells trigger an innate allergic immune response in atopic dermatitis  Wen Hao Wu, PhD,
Sabine Leisten, MSc, Michiko K
Immune deficiency caused by impaired expression of nuclear factor-κB essential modifier (NEMO) because of a mutation in the 5′ untranslated region of.
Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management  Scott H. Sicherer, MD, Hugh A. Sampson, MD  Journal.
Staphylococcal exotoxins are strong inducers of IL-22: A potential role in atopic dermatitis  Margarete Niebuhr, MD, Helena Scharonow, MS, Merle Gathmann,
Autoimmune lymphoproliferative syndrome caused by a homozygous FasL mutation that disrupts FasL assembly  Ali Sobh, MD, Elena Crestani, MD, Brittney Cangemi,
Immunologic reconstitution following hematopoietic stem cell transplantation despite lymph node paucity in NF-κB–inducing kinase deficiency  Khaoula Ben.
Direct ex vivo analysis of allergen-specific CD4+ T cells
Autophagy: Nobel Prize 2016 and allergy and asthma research
Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment
Advances in the approach to the patient with food allergy
A novel hypomorphic mutation in STIM1 results in a late-onset immunodeficiency  Heidi Schaballie, MD, Rémy Rodriguez, MS, Emmanuel Martin, PhD, Leen Moens,
Persistence of natural killer cells with expansion of a hypofunctional CD56−CD16+KIR+NKG2C+ subset in a patient with atypical Janus kinase 3–deficient.
Association between specific timothy grass antigens and changes in TH1- and TH2-cell responses following specific immunotherapy  Véronique Schulten, PhD,
Matthew J. Loza, PhD, Susan Foster, PhD, Stephen P
Allogeneic transplantation successfully corrects immune defects, but not susceptibility to colitis, in a patient with nuclear factor-κB essential modulator.
Influence of cytomegalovirus infection on immune cell phenotypes in patients with common variable immunodeficiency  Sayed Mahdi Marashi, PhD, Mohammed.
Deficiency of caspase recruitment domain family, member 11 (CARD11), causes profound combined immunodeficiency in human subjects  Polina Stepensky, MD,
Autoimmune lymphoproliferative syndrome caused by homozygous FAS mutations with normal or residual protein expression  Nourhen Agrebi, PhD, Lamia Sfaihi.
TH9 immunodeficiency in patients with hyper-IgE syndrome
Heterozygous N-terminal deletion of IκBα results in functional nuclear factor κB haploinsufficiency, ectodermal dysplasia, and immune deficiency  Douglas.
Measles and immunomodulation
Macrolide antibiotics and asthma treatment
Severe cutaneous human papillomavirus infection associated with natural killer cell deficiency following stem cell transplantation for severe combined.
Janet Chou, MD, Maxim Lutskiy, MD, PhD, Erdyni Tsitsikov, PhD, Luigi D
Azzedine Tahiat, PharmD, Yousef R
F-BAR domain only protein 1 (FCHO1) deficiency is a novel cause of combined immune deficiency in human subjects  Enrica Calzoni, MD, Craig D. Platt, MD,
Natural history of cow’s milk allergy
Primary prevention of asthma and allergy
Advances in basic and clinical immunology in 2016
CARD9 mutations linked to subcutaneous phaeohyphomycosis and TH17 cell deficiencies  Xiaowen Wang, MD, Wenyan Wang, PhD, Zhimiao Lin, MD, Xiaolin Wang,
Presentation transcript:

Combined immunodeficiency in a patient with c-Rel deficiency Sarah Beaussant-Cohen, MD, Faris Jaber, MD, Michel J. Massaad, PhD, Sabrina Weeks, BA, Jennifer Jones, BA, Mohammed F. Alosaimi, MD, Jacqueline Wallace, BSPH, Waleed Al-Herz, MD, Raif S. Geha, MD, Janet Chou, MD  Journal of Allergy and Clinical Immunology  Volume 144, Issue 2, Pages 606-608.e4 (August 2019) DOI: 10.1016/j.jaci.2019.05.003 Copyright © 2019 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 A, Representative electrophoresis (left) and densitometric quantification of REL cDNA from EBV-LCLs from control subjects and the patient. B, Schematic of REL cDNA and protein, with the patient's deleted nucleotides and residues in red. C, Representative immunoblot of c-Rel in lysates of PBMCs from the patient and control subjects. D, CD3+ T-cell proliferation to PHA, as measured by means of CellTrace Violet (CTV) dilution. E, IL-2 secretion from PBMCs from the patient and control subjects with or without PHA stimulation. F, CD3+ T-cell proliferation to PHA plus IL-2. G and H, Secretion of IFN-γ (Fig 1, G) and IL-23 (Fig 1, H) by PBMCs from the patient and control subjects cultured with the indicated stimuli. I and J, Secretion of IL-12 (Fig 1, I) and IL-8 (Fig 1, J) by EBV-LCLs from the patient and control subjects stimulated with phorbol 12, 13-dibutyrate stimulation. K, CD19+ B-cell proliferation to anti-CD40 plus IL-21. L, IL-21 secretion by PHA blasts from the patient or control subjects with or without PHA plus IL-23 stimulation. M, Schematic of the contribution of c-Rel to adaptive and innate immunity. *P < .05 and **P < .01. n.s., Not significant. Data in Fig 1, A, E, G–J, and L are pooled from 2 independent experiments; data in Fig 1, C, D, F, and K, are representative of 2 to 3 independent experiments. C, Control subjects; Pt, patient. Journal of Allergy and Clinical Immunology 2019 144, 606-608.e4DOI: (10.1016/j.jaci.2019.05.003) Copyright © 2019 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E1 Chromatograms of Sanger sequencing of the REL mutation in the patient, his parents, and his healthy brother. Journal of Allergy and Clinical Immunology 2019 144, 606-608.e4DOI: (10.1016/j.jaci.2019.05.003) Copyright © 2019 American Academy of Allergy, Asthma & Immunology Terms and Conditions